The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis, marking the company’s entry into immuno-dermatology ...
The Mirror US on MSN8mon
FDA approves 'miracle' drug that can slow Alzheimer's by 'scraping brain plaque'The Food and Drug Administration gave the nod to Eli Lilly's new medication, Kisunla, on Tuesday. The medication targets mild ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback